These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17922313)

  • 1. Polyhemoglobin-fibrinogen: a novel oxygen carrier with platelet-like properties in a hemodiluted setting.
    Wong NS; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(5):481-9. PubMed ID: 17922313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram.
    Yu B; Liu Z; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):159-73. PubMed ID: 16537172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polyhemoglobin-based model of an artificial oxygen carrier with functional properties similar to blood].
    Khachatur'ian AA; Shlimak VM; Azhigirova MA; Viazova EP; Zeĭnalov AM
    Biull Eksp Biol Med; 1981 Mar; 91(3):311-3. PubMed ID: 7248504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental assessment of the effectiveness of modified polyhemoglobin in the model of extreme hemodilution].
    Kolonina IR; Litvinenko IuA; Sokolov AV
    Biull Eksp Biol Med; 1991 May; 111(5):503-5. PubMed ID: 1878566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation dynamics after hemodilution with polyhemoglobin.
    Kim HW; Stubdal H; Greenburg AG
    Surg Gynecol Obstet; 1992 Sep; 175(3):219-26. PubMed ID: 1381112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of partial and total isovolemic exchange transfusion in fully conscious rats using pyridoxylated polyhemoglobin solution as a colloidal oxygen-delivering blood replacement fluid.
    Keipert PE; Chang TM
    Vox Sang; 1987; 53(1):7-14. PubMed ID: 3660771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glutaraldehyde concentration on the physical properties of polymerized hemoglobin-based oxygen carriers.
    Eike JH; Palmer AF
    Biotechnol Prog; 2004; 20(4):1225-32. PubMed ID: 15296452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects after partial exchange transfusion with pyridoxylated polyhemoglobin in chimpanzees.
    Lenz G; Junger H; van den Ende R; Brotman B; Prince AM
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):709-18. PubMed ID: 1810405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen transport by pyridoxylated polyhemoglobin solution.
    Lenz G; Bissinger U; Benzing H
    Adv Exp Med Biol; 1990; 277():237-46. PubMed ID: 2096629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exchange-transfusion with pyridoxalated polymerized hemoglobin: effects on liver PO2.
    Wehry M; Penner J; Campbell F; Mullins R; Rink R
    Circ Shock; 1987; 23(4):249-61. PubMed ID: 3690818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of pyridoxylated polyhemoglobin after partial exchange transfusion in chimpanzees.
    Lenz G; Junger H; Schneider M; Kothe N; Lissner R; Prince AM
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(4):699-708. PubMed ID: 1810404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo enzyme studies of polyhemoglobin-tyrosinase.
    Yu B; Chang TM
    Biotechnol Bioeng; 2004 Jun; 86(7):835-41. PubMed ID: 15162460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of NaBH4 concentration and reaction time on physical properties of glutaraldehyde-polymerized hemoglobin.
    Eike JH; Palmer AF
    Biotechnol Prog; 2004; 20(3):946-52. PubMed ID: 15176903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does OxyVita, a new-generation hemoglobin-based oxygen carrier, or oxyglobin acutely interfere with coagulation compared with normal saline or 6% hetastarch? An ex vivo thromboelastography study.
    Jahr JS; Weeks DL; Desai P; Lim JC; Butch AW; Gunther R; Driessen B
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):34-9. PubMed ID: 18249328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Jun; 40(3):197-9. PubMed ID: 22409281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo effects of stroma-free hemoglobin and polyhemoglobin on coagulation factors in rats.
    Ning J; Chang TM
    Int J Artif Organs; 1990 Aug; 13(8):509-16. PubMed ID: 2228294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
    Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
    D'Agnillo F; Chang TM
    Nat Biotechnol; 1998 Jul; 16(7):667-71. PubMed ID: 9661202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobiotechnology for hemoglobin-based blood substitutes.
    Chang TM
    Crit Care Clin; 2009 Apr; 25(2):373-82, Table of Contents. PubMed ID: 19341914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
    Bian Y; Rong Z; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):28-37. PubMed ID: 21689051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.